#news #biotech GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again, this time in lung cancer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again, this time in lung cancer .GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again, this time in lung cancer
ntaylor
Wed, 07/28/2021 – 08:54

from FierceBiotech: Biotech https://ift.tt/3rEbVG8